I agree, that if this company had an FDA approved drug with no side effects and 100% 5 year survival rate, lets say for colon cancer alone, it would be worth close to $1000 a share.
Point is, we are not there yet, many others have tried and failed. So yes, IMGN is a good investment, and I am long on it for now, however, it is just another STOCK, things may or may not workout, and one should be just as cautious with it as with any other investment.
By the way, todays action feels good, however, one concern is the volume. Yesterday's recovery came on lower volume then Monday's decline. Hope we get better volume today, to indicate institutional participation.
Also, according to IBD, Nasdaq followed through yesterday, and the Bear Market is suspended for now...... |
